North America Smart Orthopedic Implants Market Size, Share, and COVID-19 Impact Analysis, By Application (Knee Implants, Hip Implants, and Others), By Implant Component (Implants Component and Electric Components), By Procedure (Total Replacement, Partial Replacement, and Others), By End Use (Hospitals, Research Institutes, and Others), and North America Smart Orthopedic Implants Market Insights, Industry Trend, Forecasts to 2035

North America Smart Orthopedic Implants Market Size Insights Forecasts to 2035

• The North America Smart Orthopedic Implants Market Size Was Estimated at USD 12500.3 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 3.75% from 2025 to 2035
• The North America Smart Orthopedic Implants Market Size is Expected to Reach USD 18735.7 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, The North America Smart Orthopedic Implants Market Size is anticipated to Reach USD 18735.7 Million by 2035, Growing at a CAGR of 3.75% from 2025 to 2035. The smart orthopedic implants market in the North American region is driven by the clinical burden of arthritis, strong government support through grants, innovative programs and reimbursement schemes, and digital transformation in healthcare.

Market Overview

Smart orthopedic implants are defined as traditional prosthetic hardware, such as knee or hip replacements, integrated with micro-sensors and wireless electronics to provide real-time diagnostic data on post-operative parameters like load-bearing, gait metrics, and range of motion. In North America, the market is primarily propelled by a high clinical burden; approximately 1 in 5 US adults (roughly 53 million) suffer from doctor-diagnosed arthritis, a leading indicator for joint surgery. Innovations are increasingly focused on active monitoring systems, including self-powered sensors that harvest energy from patient movement to transmit kinematic data directly to clinicians. Government support acts as a critical accelerator, with the National Institutes of Health (NIH) recently awarding multimillion-dollar research grants (ranging from USD 2.3 million to USD 2.5 million) to advance sensor-integrated hardware. Additionally, the FDA’s Breakthrough Devices Program provides fast-track pathways for high-impact technologies, such as antimicrobial coatings designed to reduce infection rates. Market growth is further sustained by the Centers for Medicare & Medicaid Services (CMS) through expanded reimbursement for Remote Patient Monitoring (RPM). These federal incentives, coupled with an aging population and a shift toward value-based care, are rapidly transitioning the North American orthopedic sector toward a data-driven, personalized recovery model.

Report Coverage

This research report categorizes the North America smart orthopedic implants market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the North America Smart Orthopedic Implants market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the North America smart orthopedic implants market.

Driving Factors

The smart orthopedic implants market in North America is driven by the aggressive digital transformation of healthcare, and the integration of Internet of Things (IoT) sensors enables continuous Remote Patient Monitoring (RPM), significantly reducing the financial burden of hospital readmissions by detecting early signs of infection or implant loosening. The market is also strengthened by North America’s robust regulatory infrastructure, specifically the FDA’s Breakthrough Devices Program, which accelerates the commercialization of sensor-integrated hardware. And, the rise of robotic-assisted surgery and outpatient orthopedic centers creates a high-tech ecosystem that naturally favors the adoption of data-capable implants, allowing for a more personalized, proactive approach to musculoskeletal health.

Restraining Factors

The orthopedic implants market in North America is mostly constrained by high initial costs and complex reimbursement frameworks, and stringent regulatory pathways for electronically integrated hardware extend product development timelines. Concerns regarding patient data privacy and the potential for cybersecurity breaches in wireless implants also create hesitancy among both clinicians and patients.

Market Segmentation

The North America smart orthopedic implants market share is classified into application, implant components, procedure, and end use.

• The knee implants segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The North America smart orthopedic implants market is segmented by application into knee implants, hip implants, and others. Among these, the knee implants segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. Due to the massive volume of annual knee arthroplasty procedures and the successful commercialization of FDA-cleared smart knee systems. These devices are highly sought after in North America because they provide clinicians with precise, objective data on patient gait and range of motion, which are vital for managing the recovery of a large and active aging population.

• The implant components segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. 

Based on implant components, the North America smart orthopedic implants market is segmented into implant components and electric components. Among these, the implant component segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Because it serves as the essential structural foundation for any orthopedic surgery, the high-grade materials and manufacturing complexity of the implant component itself account for the majority of the total market value and long-term mechanical stability.

• The total replacement segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The North America smart orthopedic implants market is segmented by procedure into total replacement, partial replacement, and others. Among these, the total replacement segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. Smart orthopaedics is most effectively utilized in patients with advanced-stage joint degeneration requiring complete reconstruction. By total replacement of the entire joint, the smart orthopedic systems can capture a comprehensive dataset of the new joint’s mechanical environment, offering maximum value for surgeons monitoring post-surgical alignment and wear.

• The hospitals segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.

Based on the end use, the North America smart orthopedic implants market is segmented by hospitals, research institutes, and others. Among these, the hospitals segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Because hospitals represent the most significant end-use segment because they provide the specialized surgical robotics and IT infrastructure necessary to manage sensor-integrated hardware. Their ability to centralize complex surgical workflows and maintain the data-management platforms required for remote patient monitoring makes them the primary adopters of these advanced orthopedic solutions.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the North America smart orthopedic implants market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Zimmer Biomet Holdings
• Stryker Corporation
• DePuy Synthes
• Smith & Nephew
• Medtronic
• Canary Medical
• Exactech
• OrthoGrid
• Globus Medical
• OrthAlign
• Envois Corporation
• Orthofix Medical
• Arthrex
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments:

• In October 2025, Zimmer launched the Gorilla Pilon Fusion and Phantom TTC systems. These are considered smart-ready platforms designed to integrate with Zimmer’s digital data ecosystem (ZBEdge).

Market Segment

This study forecasts revenue at the North America, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the North America smart orthopedic implants market based on the below-mentioned segments:

North America Smart Orthopedic Implants Market, By Application

• Knee Implants
• Hip Implants
• Others

North America Smart Orthopedic Implants Market, By Implant Components

• Implant components
• Electric components

North America Smart Orthopedic Implants Market, By Procedure

• Total Replacement
• Partial Replacement
• Others

North America Smart Orthopedic Implants Market, By End Use

• Hospitals
• Research Institutes
• Others